Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment
Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment have?
Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment has 404 citations in the OpenAlex counts ScholarIQ stores.
When was Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment published?
Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment has 2017 year in the ScholarIQ index.
What is the open-access status of Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment?
Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment has closed oa status in the ScholarIQ index.
What is the DOI of Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment?
The DOI for Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment is on the source record.
What is the PMID of Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment?
The PMID for Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment is on the source record.
What is the OpenAlex record for Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment?
The OpenAlex for Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment is on the source record.